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Abstract
Aim: Periodontitis is a chronic inflammatory disease, characterized by irreversible
destruction of tooth-supporting tissue including alveolar bone. We recently
reported mucin 4 (MUC4) and matrix metalloproteinase 7 (MMP7) as highly
associated with periodontitis in gingival tissue biopsies. The aim of this study was
to further investigate the levels of MUC4 and MMP7 in saliva and gingival
crevicular fluid (GCF) samples of patients with periodontitis.
Materials and Methods: Saliva and GCF samples were collected from periodonti-
tis patients and healthy controls. The levels of MUC4, MMP7, and total protein
concentrations were analysed using ELISA or Bradford assay.
Results: MUC4 levels were significantly lower in saliva and GCF from periodon-
titis patients relative to healthy controls. MMP7 levels were significantly higher in
saliva and GCF from periodontitis patients. Multivariate analysis revealed that
MUC4 was significantly associated with periodontitis after adjusting for age and
smoking habits and, moreover, that the combination of MUC4 and MMP7 accu-
rately discriminated periodontitis from healthy controls.
Conclusions: MUC4 and MMP7 may be utilized as possible novel biomarkers for
periodontitis.
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Periodontitis is an infection-induced
chronic inflammatory disease, which,
in its severe form, affects 9–15% of
the adult population worldwide
(Petersen & Ogawa 2005, Eke et al.
2012, Kassebaum et al. 2014). The
disease may lead to irreversible
destruction of tooth-supporting tis-
sue including alveolar bone and, if
left untreated, tooth loss. Periodonti-
tis is initiated by a biofilm formation
on the teeth, in proximity to the
gingival tissue. Products from the
biofilm, such as lipopolysaccharides
(LPS), get access to the gingival tis-
sue, initiating an immune and
inflammatory response. This results
in release of inflammatory
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mediators, including cytokines, pros-
taglandins, and reactive oxygen spe-
cies, as well as proteolytic enzymes
such as matrix metalloproteinases
(MMPs). The production of these
proinflammatory mediators collec-
tively, in cascades, contributes to
destruction of gingival tissue and
alveolar bone surrounding the teeth
(Sorsa et al. 2006, Hernandez et al.
2011, Yucel-Lindberg & Bage 2013).
The first line of defence against
microbes is the saliva, which con-
tains various proteins involved in
innate and acquired immune activa-
tion. Some of these proteins, such as
immunoglobulins and chaperokine
HSP70/HSPA are involved in both
innate and acquired immune activa-
tion, while certain salivary proteins,
including cationic peptides, lyso-
zyme, amylase, cystatins, proline-rich
proteins, peroxidases, statherins, and
mucins are mainly involved in innate
immunity (Fabian et al. 2012).
Mucins play a central role in
innate immunity by promoting
aggregation and clearance of bacte-
ria from the oral cavity. Mucins are
the main gel-forming component of
the salivary film that covers the
epithelium, functioning as a diffu-
sion membrane against pathogenic
substances (Hollingsworth & Swan-
son 2004, Derrien et al. 2010). The
mucin family consists of at least 20
members (Frenkel & Ribbeck 2015),
which can be broadly classified into
two subgroups, namely secreted and
cell surface mucins (Derrien et al.
2010). Secreted mucins act by modu-
lating other proteins in the saliva as
well as by interacting with microbes
to facilitate their removal and reduce
their pathogenicity (Frenkel & Rib-
beck 2015).
The activation of proinflam-
matory cytokines, in response to
microbial products, also stimulates
up-regulation of proteolytic enzymes,
including MMPs. Structurally
related but genetically distinct
MMPs are the main proteins res-
ponsible for extracellular matrix
remodelling and are considered to
contribute to the pathogenesis of
periodontitis through destruction of
periodontal tissue (Sorsa et al. 2006,
Silva et al. 2015). Furthermore,
they can process various bioactive
non-matrix substrates including
cytokines, chemokines, complement
components, serum proteins and cell
signalling, and serum molecules,
thereby modulating immune
responses (Sorsa et al. 2006, Hernan-
dez et al. 2011). Several MMPs,
including MMP8 and MMP9, have
repeatedly been reported as elevated
in saliva and gingival crevicular fluid
(GCF) samples of periodontitis
patients (Mantyla et al. 2003, Pozo
et al. 2005, Beklen et al. 2006, Miller
et al. 2006, Passoja et al. 2008, Rai
et al. 2008, Hernandez Rios et al.
2009, Ramseier et al. 2009, Gursoy
et al. 2010, Isaza-Guzman et al.
2011, Kinane et al. 2011, Rath-
nayake et al. 2013, Sorsa et al.
2016). The activity of MMPs is con-
trolled at gene expression level, by
activation of their proenzymes, and
by inhibition via specific inhibitors,
such as tissue inhibitors of matrix
metalloproteinases (TIMPs) (Fol-
gueras et al. 2004, Sbardella et al.
2012, Silva et al. 2015). These inhibi-
tors are tissue specific endogenous
inhibitors of metalloproteinases
(Arpino et al. 2015). A disturbed
ratio between MMPs and TIMPs
causes an imbalance in the tissue
breakdown and repair of the extra-
cellular matrix (Al-Azri et al. 2013).
The regulation of MMP activity is
crucial for tissue homoeostasis (Al-
Azri et al. 2013, Khokha et al.
2013).
We have recently reported MUC4
and MMP7 as differentially
expressed in gingival tissue biopsies
from periodontitis patients and
healthy controls, analysed by RNA
sequencing. The protein products of
these genes were also confirmed as
differentially expressed in gingival
tissue biopsies from periodontitis
patients and healthy controls (Lund-
mark et al. 2015). In this study, we
aim to further investigate the levels
of MUC4 and MMP7 in saliva and
GCF samples from periodontitis
patients and healthy controls.
Materials and methods
Ethics statement
This study was performed in accor-
dance with the Declaration of Hel-
sinki and current Swedish legislation.
The sample collection was approved
by the Ethical Board at the Univer-
sity of Lund with reference number
513/2006 and by the Regional Ethi-
cal Review Board in Stockholm with
reference number 2014/1588 – 32/3.
Written informed consent was
obtained from all participants.
Collection and preparation of saliva
samples
For analysis of saliva samples, indi-
viduals with periodontitis (n = 37)
and healthy controls (n = 39) from a
population from southern Sweden
undergoing dental examination
(Lundegren et al. 2012) were
included in this study. Anamnestic
data including diseases and smoking
habits were collected. For the
patients diagnosed with periodonti-
tis, gingival inflammation, registered
as bleeding on probing (BOP), was
more than 30% and all patients had
loss of supporting tissues exceeding
1/3 of the root length, determined
through radiographical examina-
tions. The majority of these patients
(84%) had pocket probing depth
(PPD) ≥ 6 mm and six patients
(16%) had PPD 4–5 mm. The
healthy controls included individuals
with no signs of bone loss on radio-
graphs, PPD < 4 mm, and BOP less
than 30%.
Stimulated saliva samples were
obtained by chewing paraffin tablets
for 5 min while the saliva was col-
lected into test tubes. After collec-
tion, the saliva samples were
immediately frozen at 20°C until
further processing. The samples
where then thawed and centrifuged
at 500 g for 10 min at 4°C. The
supernatants were aliquoted into
1.5 ml Eppendorf tubes and stored
at 80°C until analysis.
Analysis of salivary levels of total protein,
MUC4, and MMPs
The total protein concentrations
were measured using the Bradford
assay (Bio-Rad, Hercules, CA, USA)
according to the manufacturer’s
instructions, using bovine serum
albumin as standard. The levels of
MUC4 and MMP7 were measured
using commercially available ELISA
kits according to the respective man-
ufacturer’s protocols (MUC4:
Kamiya Biomedical Company, Seat-
tle, WA, USA, MMP7: Quantikine;
R&D Systems, Minneapolis, MN,
USA). Before analysis of MUC4 and
MMP7, the saliva samples were
diluted 1:2 in phosphate buffered
© 2016 The Authors. Journal of Clinical Periodontology Published by John Wiley & Sons Ltd.
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saline (PBS) and in calibrator diluent
buffer respectively. The sensitivities
for the assays used were 0.134 ng/ml
for MUC4, 0.084 ng/ml for MMP7,
and 0.08 ng/ml for MMP8 (Tuo-
mainen et al. 2007). After optical
density readings, all readings that
fell below the assay sensitivity were
set to the lowest point of the assay
sensitivity. The levels of MMP8 were
measured by a time-resolved
immunofluorometric assay, using
monoclonal MMP8-antibody 8708
(Medix Biochemica, Kauniainen,
Finland) as capture antibody and
monoclonal MMP8-antibody 8706
(Medix Biochemica) labelled with
europium-chelate as tracer antibody.
Saliva samples were diluted 1:4 in
assay buffer (20 mM Tris-HCl [pH
7.5], 0.5 M NaCl, 5 mM CaCl2,
50 lM ZnCl2, 0.5% bovine serum
albumin, 0.05% sodium azide, and
20 mg/l diethylenetriaminepen-
taacetic acid) and incubated with the
capture antibody for 1 h, followed
by incubation for 1 h with the tracer
antibody. Enhancement solution was
then added and fluorescence was
measured after 5 min using a 1234
Delfia Research Fluorometer (Wal-
lac, Turku, Finland) (Hanemaaijer
et al. 1997, Gursoy et al. 2010).
Collection and preparation of GCF
samples
Gingival crevicular fluid samples
were collected from an additional
cohort consisting of 20 periodontitis
patients, enrolled at a periodontal
clinic, and 20 healthy controls. For
the patients diagnosed with peri-
odontitis, GCF was collected from
sites with PPD ≥ 6 mm. For the
healthy controls, GCF was collected
from sites with PPD ≤ 3 mm. Before
sample collection, supragingival pla-
que was removed from the tooth
surface using a cotton pellet and the
surface was gently dried with air.
GCF samples were collected from
the buccal (mesial and distal) sites
from one tooth by inserting two sep-
arate paper strips (Periopaper, Pro-
flow Inc., Amityville, NY, USA)
into the gingival crevice until slight
resistance was felt, and leaving them
for 30 s. GCF samples visibly con-
taminated with blood were dis-
carded. Immediately after GCF
collection, the paper strips were fro-
zen at 20°C until further
processing. Thereafter, the two paper
strips were placed into a vial con-
taining 175 ll PBS with 0.05%
Tween-20, vortexed for 30 s, and
stored at 80°C. The levels of
MUC4 (diluted 1:2 in PBS buffer)
and MMP7 in the GCF solutions
were determined using commercial
ELISA kits as described above for
the saliva samples.
Statistical analysis
Comparisons of patient characteris-
tics were performed with Mann–
Whitney U-test for continuous
variables, and cross tables were con-
structed for dichotomous variables.
If all cell values exceeded five,
Chi-square test was used, otherwise
Fisher’s exact test was used. For
boxplots, univariate analyses of pro-
tein levels between patients with
periodontitis and healthy controls
were performed with Mann–Whitney
U-test. Multiple linear regression
analyses were used with the concen-
trations of the proteins as dependent
variables. In order to achieve nor-
mality, the dependent variables were
first log-transformed. Periodontitis,
age, and smoking habits were
included as independent variables. In
order to evaluate the discriminative
power of MUC4 and MMP7, a
logistic regression analysis was per-
formed with periodontitis as depen-
dent variable. The ratio of MUC4
over MMP7 related to total protein
concentrations, as well as age and
smoking habits, was included as
independent variables. This was fol-
lowed by construction of a receiver
operating characteristic (ROC) curve
and calculation of area under curve
(AUC) using the pROC package
(Robin et al. 2011). All statistical
analyses were performed using soft-
ware R (R Core Team 2015) and dif-
ferences were considered significant
at a p-value < 0.05.
Results
Subject characteristics
The characteristics of the study par-
ticipants including patients with peri-
odontitis (n = 37) and healthy
controls (n = 39) from which saliva
samples were obtained are presented
in Table 1. The mean age of subjects
was higher in the periodontitis group
compared to the healthy controls
(62.0 and 37.6 years, respectively,
p < 0.01). In the periodontitis
group, the number of sites with PPD
4–5 mm and ≥6 mm were signifi-
cantly (p < 0.01) higher compared to
the periodontally healthy individuals
with no sites with PPD 4 mm or
more. The majority (84%) of the
patients with periodontitis had
PPD ≥ 6 mm and six patients (16%)
had PPD 4–5 mm. The number of
sites with plaque was also signifi-
cantly (p < 0.01) higher in the peri-
odontitis group than in the control
group (mean plaque index 38% and
12% respectively). In addition, the
number of sites with BOP was signif-
icantly (p < 0.01) higher in the peri-
odontitis group compared to the
control group (mean BOP index
54% and 12% respectively). The
number of individuals with high
Table 1. Characteristics of study participants from whom saliva samples were obtained
Characteristics Periodontitis
(n = 37)
Healthy controls
(n = 39)
p-value
Age (years, mean  SD) 62.0  10.9 37.6  13.3 <0.01a
Sex (female/male) 18/19 25/14 NSb
Smokers (n) 8 6 NSb
PPD 4–5 mm (number of sites, mean  SD) 23.4  12.2 0 <0.01a
PPD ≥ 6 mm (number of sites, mean  SD) 5.4  5.1 0 <0.01a
Plaque (number of sites, mean  SD) 23.0  11.9 12.7  0 <0.01a
BOP (number of sites, mean  SD) 32.0  10.5 13.3  0 <0.01a
High blood pressure/heart disease (n) 13 0 <0.01c
Diabetes (n) 4 0 NSc
Bowel diseases (n) 2 5 NSc
Muscle and joint diseases (n) 15 9 NSb
PPD, Pocket probing depth; BOP, Bleeding on probing.
ap-value determined using Mann–Whitney U-test.
bp-value determined using Chi-square test.
cp-value determined using Fisher’s two-tailed exact test.
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blood pressure or heart disease was
significantly (p < 0.01) higher in the
group of periodontitis patients than
in the healthy control group,
whereas the number of subjects with
diabetes, bowel disease, or muscle
and joint diseases were not signifi-
cantly different between the groups
(Table 1).
MUC4 and MMP7 levels in saliva samples
The levels of MUC4 and MMP7 in
saliva samples from patients with
periodontitis and healthy controls
are demonstrated in Fig. 1. Salivary
concentrations of MUC4 were signif-
icantly (p < 0.01) lower in patients
with periodontitis relative to healthy
controls. MMP7 concentrations, on
the other hand, were significantly
(p < 0.05) higher in periodontitis
patients. In addition, the total pro-
tein concentrations were significantly
(p < 0.01) higher in patients with
periodontitis (Table S1). When relat-
ing the levels of MUC4 and MMP7
to the total protein concentrations,
MUC4 levels were also significantly
(p < 0.01) lower in saliva samples
from periodontitis patients. The
ratio of MMP7 over total protein
concentration was, however, not sig-
nificantly different in saliva samples
obtained from periodontitis patients
relative to controls (Fig. 1 and
Table S1).
In order to validate our novel
biomarkers of salivary proteins for
periodontitis, the levels of MMP8
were also determined since it has
repeatedly been reported to be up-
regulated in periodontitis compared
to healthy controls. In agreement
with MMP7, the salivary levels of
MMP8 were significantly (p < 0.01)
higher in periodontitis patients rela-
tive to controls without periodontal
disease (Fig. 2 and Table S1). How-
ever, the levels of MMP8 related to
the total protein concentrations did
not significantly differ between the
two groups (Fig. 2 and Table S1).
Regression analyses for salivary levels of
MUC4 and MMP7
Multiple linear regression analyses
were performed to investigate the
impact of periodontitis on the sali-
vary levels of MUC4 and MMP7,
adjusted for age and smoking habits
(Table 2). The analyses were
performed using the total concentra-
tions of MUC4 and MMP7 as well
as their concentrations related to the
total protein levels. The results
revealed that periodontitis con-
tributed significantly (p < 0.05) to
the levels of MUC4 in saliva sam-
ples, when adjusting for age and
Fig. 1. Salivary levels of mucin 4 (MUC4) and matrix metalloproteinase 7 (MMP7).
Boxplots demonstrating the concentrations of (a) MUC4 (ng/ml), (b) MUC4/total
protein concentrations (ng/mg), (c) MMP7 (ng/ml), and (d) MMP7/total protein con-
centrations (ng/mg) in saliva samples from periodontitis patients and healthy controls.
*p < 0.05, **p < 0.01.
Fig. 2. Levels of matrix metalloproteinase 8 (MMP8) in saliva samples. Boxplots
demonstrating the concentrations of (a) MMP8 (ng/ml), and (b) MMP8/total protein
concentrations (ng/mg) in saliva samples from patients with periodontitis and healthy
controls. **p < 0.01.
Table 2. Multiple linear regression analyses of the association between salivary protein
levels and periodontitis, adjusted for age and smoking
Dependent variable Independent variable Estimate SE p-value 95% CI
MUC4 Periodontitis 0.92 0.43 0.03 1.77 to 0.07
Age 0.00 0.02 0.78 0.03 to 0.02
Smoking 0.41 0.39 0.29 0.35 to 1.17
MUC4/total protein Periodontitis 1.20 0.40 <0.01 2.00 to 0.39
Age 0.01 0.01 0.45 0.03 to 0.01
Smoking 0.34 0.37 0.36 0.38 to 1.06
MMP7 Periodontitis 0.44 0.24 0.07 0.04 to 0.92
Age 0.00 0.01 0.89 0.01 to 0.01
Smoking 0.57 0.22 0.01 1.00 to 0.14
MMP7/total protein Periodontitis 0.16 0.25 0.53 0.34 to 0.65
Age 0.00 0.01 0.54 0.02 to 0.01
Smoking 0.65 0.23 <0.01 1.09 to 0.21
Statistically significant p-values (< 0.05) are indicated with boldface.
MUC4, mucin 4; MMP7, matrix metalloproteinase 7.
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smoking. MUC4 remained signifi-
cant (p < 0.01) also when related to
the total protein concentrations in
the saliva samples (Table 2). In addi-
tion, the analysis revealed that
smoking contributed significantly to
the levels of MMP7 as well as to
MMP7 related to total protein con-
centrations (Table 2).
Furthermore, a logistic regression
analysis was performed with peri-
odontitis as dependent variable and
the ratio of MUC4 over MMP7
related to total protein concentra-
tions, as well as age and smoking
habits as independent variables
(Table S2). The results from this
analysis revealed that the ratio of
MUC4 over MMP7 related to the
total protein concentration, as well
as age, was significantly associated
with periodontitis (p < 0.05 and
p < 0.01, respectively, Table S2). The
logistic regression analysis was there-
after used to investigate the diagnos-
tic potential of the combination of
the novel biomarkers, through con-
struction of a ROC curve. The ROC
curve analysis showed that the area
under curve was 0.931 (Fig. 3).
MUC4 and MMP7 levels in GCF samples
In addition to saliva samples, the
levels of MUC4 and MMP7 were
also investigated in GCF samples
from a cohort of 40 subjects with
periodontitis and healthy controls.
The mean age of subjects was sig-
nificantly (p < 0.01) higher in the
periodontitis group compared to the
healthy controls (67.1  9.5 and
38.5  10.9 years respectively). The
periodontitis group, comprising 10
females and 10 males, had signifi-
cantly (p < 0.01) higher PPD (mean
6.9  2.0 mm) and BOP (45%), than
the healthy control group, comprising
14 females and six males
(PPD ≤ 3 mm, BOP 5%) (Table not
shown). In agreement with our find-
ings in saliva, the total concentrations
of MUC4 as well as MUC4 related to
total protein concentration were sig-
nificantly (p < 0.05, and p < 0.01
respectively) lower in the GCF from
periodontitis patients relative to
controls (Fig. 4 and Table S3). More-
over, the levels of MMP7, as well as
the total protein concentrations, were
significantly (p < 0.01) higher in
GCF from periodontitis patients
(Fig. 4 and Table S3).
Multiple linear regression analy-
ses were also performed with the
total concentrations of MUC4 and
MMP7 as well as in relation to pro-
tein concentrations as dependent
variables, adjusted for age and
smoking habits (Table 3). The analy-
ses revealed that periodontitis was
significantly (p < 0.01) associated
with the GCF levels of MUC4, and
MUC4 related to total protein con-
centrations, as well as with the levels
of MMP7 (Table 3).
Fig. 3. Diagnostic power of mucin 4
(MUC4) and matrix metalloproteinase 7
(MMP7) by receiver operating character-
istic curve (ROC curve). The ROC curve
is based on a binary logistic regression
model with periodontitis as dependent
variable and MUC4/MMP7 levels related
to the total protein concentrations, age,
and smoking habits as independent vari-
ables.
Table 3. Multiple linear regression analyses of the association between protein levels of gin-
gival crevicular fluid (GCF) and periodontitis, adjusted for age and smoking
Dependent variable Independent variable Estimate SE p-value 95% CI
MUC4 Periodontitis 2.00 0.73 <0.01 3.49 to 0.52
Age 0.03 0.02 0.21 0.01 to 0.07
Smoking 0.00 0.67 1.00 1.32 to 1.31
MUC4/total protein Periodontitis 3.19 0.87 <0.01 4.96 to 1.41
Age 0.02 0.02 0.33 0.02 to 0.07
Smoking 0.09 0.80 0.91 1.67 to 1.48
MMP7 Periodontitis 1.27 0.37 <0.01 0.52 to 2.01
Age 0.01 0.01 0.46 0.03 to 0.01
Smoking 0.53 0.34 0.13 1.19 to 0.13
MMP7/total protein Periodontitis 0.53 0.49 0.28 0.45 to 1.52
Age 0.01 0.01 0.62 0.03 to 0.02
Smoking 0.29 0.46 0.52 1.16 to 0.59
Statistically significant p-values (< 0.05) are indicated with boldface.
MUC4, mucin 4; MMP7, matrix metalloproteinase 7.
Fig. 4. Mucin 4 (MUC4) and matrix metalloproteinase 7 (MMP7) levels in gingival
crevicular fluid (GCF) samples. Boxplots demonstrating the concentrations of (a)
MUC4 (ng/ml), (b) MUC4/total protein concentrations (ng/mg), (c) MMP7 (ng/ml),
and (d) MMP7/total protein concentrations (ng/mg) in GCF samples from periodonti-
tis patients and healthy controls. *p < 0.05, **p < 0.01.
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Discussion
We have recently reported that
MUC4 and MMP7 are highly asso-
ciated with periodontitis, as identi-
fied by RNA sequencing analysis of
gingival tissue biopsies from peri-
odontitis patients and healthy con-
trols (Lundmark et al. 2015). Here,
we report, for the first time, signifi-
cantly different levels of these two
proteins in saliva and GCF samples
from patients with periodontitis rela-
tive to healthy controls. Further-
more, in this study group, we also
show that the combination of the
salivary levels of MUC4 and MMP7
has the potential of discriminating
between individuals with and with-
out periodontitis.
In this study, protein levels of
MUC4, determined by ELISA using
specific antibodies, were significantly
lower in saliva and GCF samples of
patients with periodontitis as com-
pared to healthy controls. MUC4
has previously been implicated in
cancer, including pancreatic, breast,
and lung (reviewed in Carraway
et al. 2009). Regarding periodontitis,
previous studies have reported
higher levels of mucins in general in
saliva samples from periodontitis
patients than in healthy subjects
(Sanchez et al. 2011, 2013, Acquier
et al. 2015). These studies used, how-
ever, the Alcian blue method, which
stains glycoproteins in general and
can therefore not distinguish differ-
ent mucin family members, up to
date 20 members (Frenkel & Rib-
beck 2015). At the mRNA level, our
previous sequencing study, investi-
gating the whole transcriptome in
gingival tissue biopsies from peri-
odontitis patients and healthy con-
trols, identified higher expression of
MUC4 in gingival tissue biopsies
from patients with periodontitis
(Lundmark et al. 2015). The con-
trasting findings in tissue of gingiva
versus oral fluids may be due to the
fact that MUC4 exists in both
secreted and membrane-bound form
(Hilkens & Buijs 1988, Sheng et al.
1990, Williams et al. 2001, Linden
et al. 2008) and that the balance
between these two forms may be
altered due to reprogramming of sig-
nalling pathways of the MUC4 gene
(Andrianifahanana et al. 2005) in
response to inflammation. As a
result of the biofilm formed adjacent
to the gingival tissue, the membrane-
bound form of MUC4 may increase
in order to prevent the bacteria to
access the cell surface and to protect
the gingival tissue. This suggestion is
in line with our previous results
demonstrating increased MUC4
expression in oral epithelial cells
stimulated with LPS (Lundmark
et al. 2015). Another explanation for
the decreased levels of MUC4 in sal-
iva samples might be due to prote-
olytic degradation, either by enzymes
up-regulated by the host or
expressed by microbes (Linden et al.
2008). The decreased levels of
MUC4 in saliva might lead to a
lower capability to agglutinate and
cleanse oral pathogens, allowing bio-
film formation on the teeth, leading
to sustained inflammatory response
in periodontitis patients.
Our findings demonstrating
higher levels of MMP7 in saliva and
GCF samples from patients with
periodontitis relative to healthy con-
trols are in agreement with our
RNA sequencing results, which
revealed overexpression of MMP7 in
gingival tissue biopsies of patients
with periodontitis (Lundmark et al.
2015). Levels of MMP7 have, to our
knowledge, not previously been
reported in saliva of periodontitis
patients. With regard to GCF,
MMP7 has been reported to be ele-
vated in samples from patients with
adult periodontitis relative to GCF
samples collected from patients with
localized juvenile periodontitis and
controls (Tervahartiala et al. 2000).
Another study showed no significant
differences in levels of total MMP7
in GCF samples from 20 patients
with different periodontal diseases
and healthy controls. After correct-
ing for the volume of GCF obtained
from each site, however, the levels of
MMP7 were identified as signifi-
cantly lower in periodontitis patients
than in healthy controls (Emingil
et al. 2006). Nonetheless, one limita-
tion with this study as well as our
current study is the small number of
GCF samples and additional studies
should be performed in order to vali-
date these findings. Another limita-
tion with our study is the relatively
high age of subjects in the periodon-
titis group relative to the healthy
control group. Nevertheless, our
multiple regression analyses were
adjusted for age and therefore the
results would be applicable to
younger patients as well.
In addition to demonstrating that
the levels of MUC4 and MMP7 dif-
fer significantly between oral fluids
of patients with periodontitis and
healthy controls, in this study popu-
lation, we also confirm elevated
levels of MMP8 in saliva samples
from patients with periodontitis.
MMP8 levels have repeatedly been
demonstrated to be up-regulated in
periodontitis and the elevated levels
of MMP8 in our cohort of saliva
samples indicate a concordance of
our results with those of previous
studies (Miller et al. 2006, Ramseier
et al. 2009, Gursoy et al. 2010,
Rathnayake et al. 2013). Regarding
proinflammatory periodontal tissue
destruction cascades, it should be
noted that MMP7 can activate pro-
MMP8, thereby potentially promot-
ing periodontal disease progression
(Balbin et al. 1998).
Both MUC4 and MMP7 are
involved in tissue homoeostasis by
promoting cell proliferation and
repressing apoptosis (Ii et al. 2006,
Carraway et al. 2009). In this study,
we also show that the combination of
the salivary levels of MUC4 and
MMP7 might have a diagnostic appli-
cation. A logistic regression analysis
identified the ratio of MUC4 over
MMP7 as significantly associated
with periodontitis, and a subsequent
ROC curve analysis had a high AUC,
indicating that the combination of
MUC4 andMMP7 is able to discrimi-
nate patients with periodontitis from
healthy controls, in this study popula-
tion. A combination of biomarkers
will likely be more specific than a sin-
gle marker and future studies should
focus on panels of biomarkers,
including MUC4 and MMP7, for pre-
dicting periodontitis.
In conclusion, this study is, to the
best of our knowledge, the first to
identify significantly different levels
of MUC4 and MMP7 in saliva and
GCF of patients with periodontitis
in comparison to healthy controls,
suggesting that MUC4 and MMP7,
alone or in combination, might have
the potential to act as novel diagnos-
tic markers for periodontitis.
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Clinical Relevance
Scientific rationale for the study:
We have recently, through RNA-
sequencing, identified MUC4 and
MMP7 as highly associated with
periodontitis in gingival tissue
biopsies. However, to our knowl-
edge, no study has previously
reported these proteins in saliva
from patients with periodontitis and
healthy controls.
Principal findings: Levels of MUC4
and MMP7 were significantly differ-
ent in saliva samples from patients
with periodontitis relative to healthy
controls.
Practical implications: Our novel
findings that MUC4 and MMP7
levels differ in saliva samples from
patients with periodontitis and
healthy controls imply that they
might exert the potential to serve
as salivary biomarkers for peri-
odontitis.
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